A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.“Standard chemotherapy can be incredibly disruptive to people’s lives,” said Prof Professor Chris Twelves of the University of Leeds, who led the research. “Patients visit hospital five days a week for the injections and then have three weeks off before returning to hospital for the next course – and the side effects can be unpleasant.”
